Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3′,5′-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats

British Journal of Pharmacology

Volumn 158, Issue 6, 2009, Pages 1495-1502

  Giricz, Z ^a   Gorbe A ^a   Pipis, J ^a   Burley, D S ^b   Ferdinandy, P ^a,c   Baxter, G F ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c PHARMAHUNGARY GROUP   (Hungary)

Author keywords

BNP; CGMP; Hyperlipidaemia; Ischaemia; Protein kinase G; Rat; Troponin I

Indexed keywords

8 (4 CHLOROPHENYLTHIO) BETA PHENYL 1,N 2 ETHENOGUANOSINE 3',5' CYCLIC MONOPHOSPHOROTHIOATE; 8 BROMO CYCLIC GMP; BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE 32; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; KT 5823; LACTATE DEHYDROGENASE; N ACETYL S NITROSOPENICILLAMINE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFICACY; HEART INFARCTION; HEART PERFUSION; HEART PROTECTION; HEART RATE; HYPERLIPIDEMIA; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOTONIC AGENTS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DIETARY FATS; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NATRIURETIC PEPTIDE, BRAIN; PHOSPHORYLATION; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; TROPONIN I;

EID: 70350563942     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00424.x     Document Type: Article

References (36)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Burgoyne JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schroder E et al. (2007). Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 317 (5843 1393 1397.
3. Burley DS, Baxter GF (2007). B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart. Basic Res Cardiol 102 (6 529 541.
4. Burley DS, Ferdinandy P, Baxter GF (2007). Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152 (6 855 869.
5. Cohen MV, Yang XM, Downey JM (2006). Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70 (2 231 239.
6. + channels in rat hearts. Am J Physiol Heart Circ Physiol 290 (5 H1808 H1817.
7. Das A, Xi L, Kukreja RC (2008). Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283 (43 29572 29585.
8. D'Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A et al. (2003). B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284 (5 H1592 H1600.
9. Ferdinandy P, Schulz R (2001). Peroxynitrite: toxic or protective in the heart? Circ Res 88 (2 E12-E13.
10. Ferdinandy P, Schulz R (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138 (4 532 543.
11. Ferdinandy P, Schulz R, Baxter GF (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59 (4 418 458.
12. Giricz Z, Csonka C, Onody A, Csont T, Ferdinandy P (2003). Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis. Basic Res Cardiol 98 (5 304 310.
13. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P (2006). Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther 316 (1 154 161.
14. Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L et al. (2006). The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188 (2 356 362.
15. Juhasz B, Der P, Turoczi T, Bacskay I, Varga E, Tosaki A (2004). Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma? Antioxid Redox Signal 6 (2 325 333.
16. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT et al. (2004). Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47 (10 1716 1721.
17. Layland J, Li JM, Shah AM (2002). Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540 (Pt 2 457 467.
18. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268 (35 26286 26295.
19. Munzel T, Feil R, Mulsch A, Lohmann SM, Hofmann F, Walter U (2003). Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphate-dependent protein kinase [corrected Circulation 108 (18 2172 2183.
20. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smolenski A et al. (2000). Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 87 (11 999 1005.
21. Onody A, Csonka C, Giricz Z, Ferdinandy P (2003). Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58 (3 663 670.
22. Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R et al. (2007). Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42 (3 508 516.
23. Puskas LG, Nagy ZB, Giricz Z, Onody A, Csonka C, Kitajka K et al. (2004). Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett 562 (1-3 99 104.
24. Qin Q, Yang XM, Cui L, Critz SD, Cohen MV, Browner NC et al. (2004). Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism. Am J Physiol Heart Circ Physiol 287 (2 H712 H718.
25. Raeymaekers L, Hofmann F, Casteels R (1988). Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 252 (1 269 273.
26. Rastegar MA, Vegh A, Papp JG, Parratt JR (2000). Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs. Cardiovasc Drugs Ther 14 (5 471 479.
27. Schwemmer M, Sommer O, Koeckerbauer R, Bassenge E (2000). Cardiovascular dysfunction in hypercholesterolemia associated with enhanced formation of AT1-receptor and of eicosanoids. J Cardiovasc Pharmacol Ther 5 (1 59 68.
28. Stamm C, del Nido PJ (2004). Protein kinase C and myocardial calcium handling during ischemia and reperfusion: lessons learned using Rhod-2 spectrofluorometry. Thorac Cardiovasc Surg 52 (3 127 134.
29. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M (1994). Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol 266 (5 Pt 2 H2033 H2041.
30. Takagi G, Kiuchi K, Endo T, Yamamoto T, Sato N, Nejima J et al. (2000). Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol 36 (1 22 30.
31. Tang XL, Takano H, Xuan YT, Sato H, Kodani E, Dawn B et al. (2005). Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin- dependent mechanism in conscious rabbits. Circulation 112 (14 2149 2156.
32. Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H et al. (1999). Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol 34 (7 2120 2125.
33. Warnholtz A, Mollnau H, Heitzer T, Kontush A, Moller-Bertram T, Lavall D et al. (2002). Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. J Am Coll Cardiol 40 (7 1356 1363.
34. Xu Z, Ji X, Boysen PG (2004). Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol 286 (4 H1433 H1440.
35. Yang XM, Philipp S, Downey JM, Cohen MV (2006). Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 101 (4 311 318.
36. Yuasa K, Michibata H, Omori K, Yanaka N (1999). A novel interaction of cGMP-dependent protein kinase I with troponin T. J Biol Chem 274 (52 37429 37434.